[1]
|
Ammirati, A.L. (2020) Chronic Kidney Disease. Revista da Associacao Medica Brasileira, 66, S3-S9. https://doi.org/10.1590/1806-9282.66.s1.3
|
[2]
|
Eckardt, K.U., Coresh, J., Devuyst, O., et al. (2013) Evolving Importance of Kidney Disease: From Subspecialty to Global Health Burden. The Lancet, 382, 158-169. https://doi.org/10.1016/S0140-6736(13)60439-0
|
[3]
|
Kovesdy, C.P., Furth, S.L. and Zoccali, C. (2017) Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Brazilian Journal of Medical and Biological Research, 50, e6075. https://doi.org/10.1177/2054358117698669
|
[4]
|
Ng, J.K. and Li, P.K. (2018) Chronic Kidney Disease Epidemic: How Do We Deal with It? Nephrology (Carlton), 23, 116-120. https://doi.org/10.1111/nep.13464
|
[5]
|
Ferguson, T.W., Komenda, P. and Tangri, N. (2015) Cystatin C as a Biomarker for Estimating Glomerular Filtration Rate. Current Opinion in Nephrology and Hypertension, 24, 295-300. https://doi.org/10.1097/MNH.0000000000000115
|
[6]
|
Abrahamson, M., Olafsson, I., Palsdottir, A., et al. (1990) Structure and Expression of the Human Cystatin C Gene. Biochemical Journal, 268, 287-294. https://doi.org/10.1042/bj2680287
|
[7]
|
Tlemsani, C., Durand, J.P., Raynard, B., et al. (2022) Relationship between the Creatinine/Cystatin C Ratio and Muscle Mass Measured by CT-Scan in Cancer Patients. Clinical Nutrition ESPEN, 51, 412-418. https://doi.org/10.1016/j.clnesp.2022.07.010
|
[8]
|
Priyadarshini, G. and Rajappa, M. (2022) Predictive Markers in Chronic Kidney Disease. Clinica Chimica Acta, 535, 180-186. https://doi.org/10.1016/j.cca.2022.08.018
|
[9]
|
Fujita, K., Ohkubo, H., Nakano, A., et al. (2022) Serum Creatinine/Cystatin C Ratio Is a Surrogate Marker for Sarcopenia in Patients with Idiopathic Pulmonary Fibrosis. BMC Pulmonary Medicine, 22, Article No. 203. https://doi.org/10.1186/s12890-022-02000-3
|
[10]
|
Jiang, R., Huang, Y., Zeng, M., et al. (2023) A Marked Elevation in Serum Creatinine/Cystatin C Ratio May Indicate Pseudo-Acute Kidney Injury Due to Urinary Ascites: A Case Report and Literature Review. BMC Nephrology, 24, Article No. 243. https://doi.org/10.1186/s12882-023-03289-w
|
[11]
|
Khang, A.R., Jin, L.M., Yi, D., et al. (2023) The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients. Diabetes & Metabolism Journal, 47, 415-425. https://doi.org/10.4093/dmj.2022.0177
|
[12]
|
Grams, M.E., Coresh, J., Matsushita, K., et al. (2023) Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA, 330, 1266-1277. https://doi.org/10.1001/jama.2023.17002
|
[13]
|
Levey, A.S., Becker, C. and Inker, L.A. (2015) Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults: A Systematic Review. JAMA, 313, 837-846. https://doi.org/10.1001/jama.2015.0602
|
[14]
|
Haines, R.W., Fowler, A.J., Liang, K., et al. (2023) Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness. Clinical Journal of the American Society of Nephrology, 18, 997-1005. https://doi.org/10.2215/CJN.0000000000000203
|
[15]
|
Wang, J., Zhang, L.X., Tang, C.W., et al. (2018) Disease Burden and Challenges of Chronic Kidney Disease in North and East Asia. Kidney International, 94, 22-25. https://doi.org/10.1016/j.kint.2017.12.022
|
[16]
|
Kim, H., Park, T.J., Lee, J., et al. (2021) The Difference between Cystatin C-and Creatinine-Based EGFR Is Associated with Adverse Cardiovascular Outcome in Patients with Chronic Kidney Disease. Atherosclerosis, 335, 53-61. https://doi.org/10.1016/j.atherosclerosis.2021.08.036
|
[17]
|
Wang, X.H. and Mitch, W.E. (2014) Mechanisms of Muscle Wasting in Chronic Kidney Disease. Nature Reviews Nephrology, 10, 504-516. https://doi.org/10.1038/nrneph.2014.112
|
[18]
|
Pereira, R.A., Cordeiro, C.A., Avesani, C.M., et al. (2015) Sarcopenia in Chronic Kidney Disease on Conservative Therapy: Prevalence and Association with Mortality. Nephrology Dialysis Transplantation, 30, 1718-1725. https://doi.org/10.1093/ndt/gfv133
|
[19]
|
Carrero, J.J., Johansen, K.L., Lindholm, B., et al. (2016) Screening for Muscle Wasting and Dysfunction in Patients with Chronic Kidney Disease. Kidney International, 90, 53-66. https://doi.org/10.1016/j.kint.2016.02.025
|
[20]
|
Yanishi, M., Kimura, Y., Tsukaguchi, H., et al. (2017) Factors Associated with the Development of Sarcopenia in Kidney Transplant Recipients. Transplantation Proceedings, 49, 288-292. https://doi.org/10.1016/j.transproceed.2016.12.015
|
[21]
|
Yanishi, M., Tsukaguchi, H., Kimura, Y., et al. (2017) Evaluation of Physical Activity in Sarcopenic Conditions of Kidney Transplantation Recipients. International Urology and Nephrology, 49, 1779-1784. https://doi.org/10.1007/s11255-017-1661-4
|
[22]
|
Choi, M.C., Kim, D.G., Yim, S.H., et al. (2024) Creatinine-Cystatin C Ratio and Death with a Functioning Graft in Kidney Transplant Recipients. Scientific Reports, 14, Article No. 1966. https://doi.org/10.1038/s41598-024-52649-5
|
[23]
|
Kellum, J.A., Romagnani, P., Ashuntantang, G., et al. (2021) Acute Kidney Injury. Nature Reviews Disease Primers, 7, Article No. 52. https://doi.org/10.1038/s41572-021-00284-z
|
[24]
|
Koza, Y. (2016) Acute Kidney Injury: Current Concepts and New Insights. Journal of Injury and Violence Research, 8, 58-62.
|